Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.

Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.
复制标题

DOI:
10.1016/j.arcmed.2011.07.008
复制
发表时间:
2011-07
影响因子:
7.7
通讯作者:
Hai-Bo Wei;Xiang-shi Lu;Li-hua Shang;Gang Xu;Jing Hu;Dehai Che;Fang Liu;Ying Wu;Guang-mei Zhan
Hai-Bo Wei;Xiang-shi Lu;Li-hua Shang;Gang Xu;Jing Hu;Dehai Che;Fang Liu;Ying Wu;Guang-mei Zhan
中科院分区:
医学4区
文献类型:
--
作者:
Hai-Bo Wei;Xiang-shi Lu;Li-hua Shang;Gang Xu;Jing Hu;Dehai Che;Fang Liu;Ying Wu;Guang-mei Zhan

文献摘要

被引文献

相似文献